These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 24545658)

  • 1. Measurement of the mouse protective effect of antibody for Pseudomonas aeruginosa in burned and unburned patients' sera.
    GRABER CD; CUMMINGS D; VOGEL EH; TUMBUSCH WT
    Res Rep Brooke Army Med Cent; 1960 Oct; MEDEW RS 7 60():1-10. PubMed ID: 24545658
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of the protective effect of antibody in burned and unburned patients' sera for Pseudomonas aeruginosa infected mice.
    GRABER CD; CUMMINGS D; VOGEL EH; TUMBUSCH WT
    Tex Rep Biol Med; 1961; 19():268-76. PubMed ID: 13707611
    [No Abstract]   [Full Text] [Related]  

  • 3. Resistance transfer from Alcaligenes to Pseudomonas aeruginosa in burned and unburned germfree mice.
    Miskell PW; Maley MP; Hummel RP
    Surg Forum; 1976; 27(62):69-70. PubMed ID: 828327
    [No Abstract]   [Full Text] [Related]  

  • 4. Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.
    Jones RJ; Roe EA
    Br J Exp Pathol; 1975 Feb; 56(1):34-43. PubMed ID: 812544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study.
    Lipový B; Rihová H; Hanslianová M; Gregorová N; Suchánek I; Brychta P
    Acta Chir Plast; 2010; 52(2-4):39-43. PubMed ID: 21749009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
    Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
    Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F(ab')2-like fragments from severely burned patients provide a new serum immunoglobin component.
    Goldberg CB; Whitehouse F
    Nature; 1970 Oct; 228(5267):160-2. PubMed ID: 4990048
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity and protective efficacy of Pseudomonas aeruginosa type a and b flagellin vaccines in a burned mouse model.
    Laghaei P; Hashemi FB; Irajian G; Korpi F; Amirmozafari N; Behrouz B
    Mol Immunol; 2016 Jun; 74():71-81. PubMed ID: 27152476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAPHYLOCOCCAL ANTIBODIES IN BURNED PATIENTS.
    JONES RJ; LOWBURY EJ
    Br J Exp Pathol; 1963 Dec; 44(6):576-85. PubMed ID: 14084655
    [No Abstract]   [Full Text] [Related]  

  • 11. Major Transcriptome Changes Accompany the Growth of Pseudomonas aeruginosa in Blood from Patients with Severe Thermal Injuries.
    Kruczek C; Kottapalli KR; Dissanaike S; Dzvova N; Griswold JA; Colmer-Hamood JA; Hamood AN
    PLoS One; 2016; 11(3):e0149229. PubMed ID: 26933952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral antibody response to Pseudomonas aeruginosa in a burned mouse model.
    Subramaniam L; Shriniwas ; Kumar R; Bhujwala RA
    Indian J Med Res; 1985 Dec; 82():498-501. PubMed ID: 3938772
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of the use of agglutinating sera and phage lysis in the classification of strains of Pseudomonas aeruginosa.
    GOULD JC; McLEOD JW
    J Pathol Bacteriol; 1960 Apr; 79():295-311. PubMed ID: 13828580
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
    Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
    Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of HepP: a virulence-related Pseudomonas aeruginosa heparinase.
    Dzvova N; Colmer-Hamood JA; Griswold JA; Hamood AN
    BMC Microbiol; 2017 Dec; 17(1):233. PubMed ID: 29246112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of transforming growth factor-beta neutralization on survival and bacterial clearance in a murine model of Pseudomonas aeruginosa burn wound infection.
    Huang Z; Pereira C; Toliver-Kinsky T; Murphey ED; Varma TK; Lin CY; Herndon DN; Sherwood ER
    J Burn Care Res; 2006; 27(5):682-7. PubMed ID: 16998401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Method and result of oxygen addition in the culture process of Pseudomonas aeruginosa].
    Ji TP
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1989 Dec; 5(4):257-8, 316. PubMed ID: 2517231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PSEUDOMONAS VACCINE AND HYPERIMMUNE PLASMA IN THE TREATMENT OF BURNED PATIENTS.
    FELLER I; KAMEI I
    Surg Forum; 1964; 15():46-7. PubMed ID: 14189457
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.